Hamilton James C — SEC Form 4 filings
SEC reporting owner CIK 1830755. 11 Form 4 filings on record with FilingPulse; latest filed 2026-04-24.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-01-17 to 2026-04-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 19 legs across 10 filings — 166,833 shares, $6,761,469 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 2.
- Largest priced transaction: sale of 14,792 shares @ $63.01 ($932,044) in ARROWHEAD PHARMACEUTICALS, INC., filed 2026-01-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Chief Medical Officer | 11 | — | 19 legs · 166,833 sh · $6,761,469 | 2 |
Form 4 filings — Hamilton James C
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-24 | 4 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale (S): 10,000 @ $75 | EDGAR |
| 2026-03-09 | 4 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale (S): 10,000 @ $64.19 | EDGAR |
| 2026-01-08 | 4 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Grant/award (A): 75,000 @ $0 | EDGAR |
| 2026-01-05 | 4 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale (S): 4,625 @ $61.24 · Sale (S): 6,090 @ $62.28 · Sale (S): 14,792 @ $63.01 · Sale (S): 12,711 @ $63.95 · Sale (S): 1,200 @ $64.49 · Sale (S): 437 @ $65.97 · +1 more | EDGAR |
| 2025-10-03 | 4 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale (S): 20,000 @ $35 | EDGAR |
| 2025-09-16 | 4 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale (S): 15,000 @ $30 | EDGAR |
| 2025-09-04 | 4 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale (S): 15,000 @ $25 | EDGAR |
| 2025-08-15 | 4 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale (S): 611 @ $20 · Sale (S): 9,389 @ $20 | EDGAR |
| 2025-01-07 | 4 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Grant/award (A): 100,000 @ $0 · Sale (S): 21,758 @ $19.68 · Sale (S): 10,971 @ $20.11 | EDGAR |
| 2024-04-03 | 4 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale (S): 6,000 @ $28.03 | EDGAR |
| 2024-01-17 | 4 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale (S): 4,238 @ $36.47 · Sale (S): 3,702 @ $37.37 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1830755 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →